|1 Table of Contents……………………………………………………………………………………… 3
|1.1 List of Tables……………………………………………………………………………………. 14
|1.2 List of Figures…………………………………………………………………………………… 26
2 Introduction…………………………………………………………………………………………….. 27
2.1 Trauma Fixation Overview………………………………………………………………….. 27
3 Products under Development…………………………………………………………………….. 29
3.1 Trauma Fixation – Pipeline Products by Stage of Development……………….. 29
3.2 Trauma Fixation – Pipeline Products by Segment…………………………………… 30
3.3 Trauma Fixation – Pipeline Products by Territory…………………………………… 32
3.4 Trauma Fixation – Pipeline Products by Regulatory Path…………………………. 33
3.5 Trauma Fixation – Pipeline Products by Estimated Approval Date……………. 34
3.6 Trauma Fixation – Ongoing Clinical Trials………………………………………………. 35
4 Trauma Fixation – Pipeline Products under Development by Companies…………. 36
4.1 Trauma Fixation Companies – Pipeline Products by Stage of Development. 36
4.2 Trauma Fixation – Pipeline Products by Stage of Development……………….. 42
5 Trauma Fixation Companies and Product Overview……………………………………… 48
5.1 206 Ortho, Inc. Company Overview……………………………………………………… 48
5.1.1 206 Ortho, Inc. Pipeline Products & Ongoing Clinical Trials Overview.. 48
5.2 3D Systems Inc Company Overview……………………………………………………… 49
5.2.1 3D Systems Inc Pipeline Products & Ongoing Clinical Trials Overview.. 49
5.3 4D Medicine Ltd Company Overview……………………………………………………. 50
5.3.1 4D Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.4 4WEB Medical Inc Company Overview………………………………………………… 51
5.4.1 4WEB Medical Inc Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………………………………. 51
5.5 aap Implantate AG Company Overview………………………………………………… 52
5.5.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………………………………. 52
5.6 Acuitive Technologies Inc Company Overview………………………………………. 66
5.6.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 66
5.7 Advanced BioMedical Technologies, Inc. Company Overview…………………. 68
5.7.1 Advanced BioMedical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………… 68
5.8 AMB Surgical II LLC Company Overview……………………………………………….. 69
5.8.1 AMB Surgical II LLC Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………………………………. 69
5.9 Anika Therapeutics Inc Company Overview………………………………………….. 71
5.9.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 71
5.10 Apex Biomedical LLC Company Overview……………………………………………. 73
5.10.1 Apex Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 73
5.11 Appiades Meditech ltd. Company Overview……………………………………….. 75
5.11.1 Appiades Meditech ltd. Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 75
5.12 Aran Biomedical Company Overview………………………………………………….. 76
5.12.1 Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………………………………. 76
5.13 Argomedical AG Company Overview………………………………………………….. 77
5.13.1 Argomedical AG Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………………………………. 77
5.14 Ascendx Spine, Inc. (Inactive) Company Overview……………………………….. 78
5.14.1 Ascendx Spine, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………… 78
5.15 Axial Orthopaedics Company Overview………………………………………………. 79
5.15.1 Axial Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 79
5.16 B1 Medical Ltd (Inactive) Company Overview……………………………………… 80
5.16.1 B1 Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 80
5.17 Bactiguard Holding AB Company Overview…………………………………………. 82
5.17.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 82
5.18 BioMagnesium Systems Ltd. (Inactive) Company Overview…………………… 84
5.18.1 BioMagnesium Systems Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………… 84
5.19 Bioretec Ltd Company Overview………………………………………………………… 85
5.19.1 Bioretec Ltd Pipeline Products & Ongoing Clinical Trials Overview….. 85
5.20 Body Organ Biomedical Corp Company Overview………………………………… 88
5.20.1 Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………… 88
5.21 Boston University Company Overview……………………………………………….. 90
5.21.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………………………………. 90
5.22 Camber Spine Technologies LLC Company Overview……………………………. 91
5.22.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………… 91
5.23 CAMBfix Ltd (Inactive) Company Overview…………………………………………. 93
5.23.1 CAMBfix Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 93
5.24 Cardinal Health Inc Company Overview……………………………………………… 98
5.24.1 Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………. 98
5.25 CG Bio Inc Company Overview…………………………………………………………… 99
5.25.1 CG Bio Inc Pipeline Products & Ongoing Clinical Trials Overview…….. 99
5.26 Clear Surgical Ltd Company Overview………………………………………………. 100
5.26.1 Clear Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 100
5.27 Clemson University Company Overview……………………………………………. 101
5.27.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 101
5.28 Colorado State University Company Overview…………………………………… 102
5.28.1 Colorado State University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 102
5.29 Columbia University Company Overview………………………………………….. 103
5.29.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 103
5.30 Conventus Orthopaedics, Inc. Company Overview…………………………….. 104
5.30.1 Conventus Orthopaedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 104
5.31 Coracoid Solutions LLC Company Overview………………………………………. 107
5.31.1 Coracoid Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 107
5.32 CrossRoads Extremity Systems LLC Company Overview……………………… 109
5.32.1 CrossRoads Extremity Systems LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 109
5.33 Curtin University Company Overview……………………………………………….. 110
5.33.1 Curtin University Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 110
5.34 Dallen Medical Company Overview………………………………………………….. 111
5.34.1 Dallen Medical Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 111
5.35 DePuy Synthes Inc Company Overview…………………………………………….. 112
5.35.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 112
5.36 Drexel University Company Overview………………………………………………. 113
5.36.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 113
5.37 DSM Biomedical BV Company Overview…………………………………………… 114
5.37.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 114
5.38 Dynamic Memory Medical Technologies Ltd. Company Overview……….. 115
5.38.1 Dynamic Memory Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………. 115
5.39 Emory University Company Overview………………………………………………. 116
5.39.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 116
5.40 Endoorthopaedics, Inc. Company Overview………………………………………. 117
5.40.1 Endoorthopaedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 117
5.41 Evoke Medical LLC Company Overview…………………………………………….. 118
5.41.1 Evoke Medical LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 118
5.42 Evonik Corp Company Overview………………………………………………………. 119
5.42.1 Evonik Corp Pipeline Products & Ongoing Clinical Trials Overview… 119
5.43 Expanding Orthopedics Inc Company Overview…………………………………. 120
5.43.1 Expanding Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 120
5.44 Fuse Medical Inc Company Overview……………………………………………….. 121
5.44.1 Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 121
5.45 Hannover Medical School Company Overview…………………………………… 123
5.45.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 123
5.46 Hospital for Special Surgery Company Overview………………………………… 125
5.46.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 125
5.47 Implants International Ltd Company Overview………………………………….. 127
5.47.1 Implants International Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 127
5.48 Innovia LLC Company Overview……………………………………………………….. 131
5.48.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview…. 131
5.49 Interface Biologics Inc Company Overview………………………………………… 132
5.49.1 Interface Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 132
5.50 Intramed Systems Ltd Company Overview………………………………………… 133
5.50.1 Intramed Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 133
5.51 Johns Hopkins University Company Overview……………………………………. 134
5.51.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 134
5.52 Koc University Company Overview…………………………………………………… 135
5.52.1 Koc University Pipeline Products & Ongoing Clinical Trials Overview 135
5.53 Magloy Tech Pte Ltd Company Overview………………………………………….. 136
5.53.1 Magloy Tech Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 136
5.54 Magnesium Development Company LLC Company Overview……………… 137
5.54.1 Magnesium Development Company LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 137
5.55 McGill University Company Overview………………………………………………. 140
5.55.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 140
5.56 Medartis AG Company Overview……………………………………………………… 141
5.56.1 Medartis AG Pipeline Products & Ongoing Clinical Trials Overview.. 141
5.57 Medshape Inc Company Overview…………………………………………………… 142
5.57.1 Medshape Inc Pipeline Products & Ongoing Clinical Trials Overview 142
5.58 Medtronic Plc Company Overview……………………………………………………. 143
5.58.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 143
5.59 Meduloc LLC Company Overview…………………………………………………….. 144
5.59.1 Meduloc LLC Pipeline Products & Ongoing Clinical Trials Overview.. 144
5.60 Mel Frontier Co Ltd Company Overview……………………………………………. 145
5.60.1 Mel Frontier Co Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 145
5.61 Meta Biomed Co Ltd Company Overview………………………………………….. 146
5.61.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 146
5.62 MicroPort Scientific Corp Company Overview……………………………………. 148
5.62.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 148
5.63 Monash University Company Overview…………………………………………….. 151
5.63.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 151
5.64 Nagoya University Company Overview……………………………………………… 152
5.64.1 Nagoya University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 152
5.65 Nanova, Inc Company Overview………………………………………………………. 153
5.65.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview… 153
5.66 Nasseo, Inc. Company Overview………………………………………………………. 154
5.66.1 Nasseo, Inc. Pipeline Products & Ongoing Clinical Trials Overview… 154
5.67 National Research Tomsk Polytechnic University Company Overview….. 155
5.67.1 National Research Tomsk Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………. 155
5.68 NEOS Surgery SL Company Overview……………………………………………….. 156
5.68.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 156
5.69 Nextremity Solutions LLC Company Overview……………………………………. 157
5.69.1 Nextremity Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 157
5.70 Nuortho Surgical Inc Company Overview………………………………………….. 158
5.70.1 Nuortho Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 158
5.71 Nutek Orthopaedics Inc Company Overview……………………………………… 159
5.71.1 Nutek Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 159
5.72 Orthocell Ltd Company Overview…………………………………………………….. 162
5.72.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview. 162
5.73 Orthofix Medical Inc Company Overview………………………………………….. 163
5.73.1 Orthofix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 163
5.74 OrthoMend Research Inc Company Overview……………………………………. 164
5.74.1 OrthoMend Research Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 164
5.75 OrthoPediatrics Corp Company Overview…………………………………………. 167
5.75.1 OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 167
5.76 OrthoSensor Inc Company Overview………………………………………………… 171
5.76.1 OrthoSensor Inc Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 171
5.77 Ossio Ltd Company Overview………………………………………………………….. 172
5.77.1 Ossio Ltd Pipeline Products & Ongoing Clinical Trials Overview……. 172
5.78 Osteo Pharma BV Company Overview………………………………………………. 175
5.78.1 Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 175
5.79 Osteopore International Pte Ltd Company Overview………………………….. 176
5.79.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 176
5.80 OsteoWeld Surgical Ltd Company Overview……………………………………… 177
5.80.1 OsteoWeld Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 177
5.81 Penderia Technologies Inc Company Overview………………………………….. 178
5.81.1 Penderia Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 178
5.82 Polytechnique Montreal Company Overview…………………………………….. 179
5.82.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 179
5.83 Resoimplant GmbH (Inactive) Company Overview……………………………… 180
5.83.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 180
5.84 Resorbium Ltd Company Overview…………………………………………………… 185
5.84.1 Resorbium Ltd Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 185
5.85 Response Ortho Company Overview………………………………………………… 188
5.85.1 Response Ortho Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 188
5.86 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview……………………………………………………………………………………………… 199
5.86.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview……………………………. 199
5.87 Retendon Ltd Company Overview……………………………………………………. 201
5.87.1 Retendon Ltd Pipeline Products & Ongoing Clinical Trials Overview 201
5.88 RevBio Inc Company Overview………………………………………………………… 203
5.88.1 RevBio Inc Pipeline Products & Ongoing Clinical Trials Overview….. 203
5.89 Rowan University Company Overview………………………………………………. 205
5.89.1 Rowan University Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 205
5.90 Saint Louis University Company Overview………………………………………… 206
5.90.1 Saint Louis University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 206
5.91 Sayan Orthopaedics Ltd Company Overview……………………………………… 208
5.91.1 Sayan Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 208
5.92 Scandinavian Real Heart AB Company Overview……………………………….. 209
5.92.1 Scandinavian Real Heart AB Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 209
5.93 SeaSpine, Inc. Company Overview……………………………………………………. 210
5.93.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210
5.94 Shandong University of Traditional Chinese Medicine Company Overview……………………………………………………………………………………………………………. 211
5.94.1 Shandong University of Traditional Chinese Medicine Pipeline Products & Ongoing Clinical Trials Overview………………………………………… 211
5.95 Shenzhen Lixin Science Co Ltd Company Overview…………………………….. 212
5.95.1 Shenzhen Lixin Science Co Ltd Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 212
5.96 SI-Bone Inc Company Overview……………………………………………………….. 214
5.96.1 SI-Bone Inc Pipeline Products & Ongoing Clinical Trials Overview…. 214
5.97 SINTX Technologies Inc Company Overview………………………………………. 216
5.97.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 216
5.98 Sites Medical LLC Company Overview………………………………………………. 218
5.98.1 Sites Medical LLC Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 218
5.99 Smith & Nephew Plc Company Overview………………………………………….. 219
5.99.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 219
5.100 SpineSmith Holdings LLC Company Overview………………………………….. 221
5.100.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 221
5.101 Stanford University Company Overview………………………………………….. 222
5.101.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 222
5.102 Stryker Corp Company Overview……………………………………………………. 223
5.102.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 223
5.103 SUNY Upstate Medical University Company Overview……………………… 224
5.103.1 SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 224
5.104 Synoste Oy Company Overview……………………………………………………… 225
5.104.1 Synoste Oy Pipeline Products & Ongoing Clinical Trials Overview.. 225
5.105 Syntellix AG Company Overview…………………………………………………….. 226
5.105.1 Syntellix AG Pipeline Products & Ongoing Clinical Trials Overview. 226
5.106 Teleflex Inc Company Overview……………………………………………………… 227
5.106.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview.. 227
5.107 Tepha Inc Company Overview……………………………………………………….. 229
5.107.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview…. 229
5.108 Tesa Medical Inc Company Overview……………………………………………… 230
5.108.1 Tesa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 230
5.109 The Chinese University of Hong Kong Company Overview………………… 231
5.109.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 231
5.110 The Feinstein Institute for Medical Research Company Overview………. 232
5.110.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………. 232
5.111 The University of Nottingham Company Overview…………………………… 233
5.111.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 233
5.112 Toetal Solutions Inc Company Overview…………………………………………. 234
5.112.1 Toetal Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 234
5.113 Tyber Medical LLC Company Overview……………………………………………. 235
5.113.1 Tyber Medical LLC Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 235
5.114 UAB Minority Health and Health Equity Research Center Company Overview……………………………………………………………………………………………… 236
5.114.1 UAB Minority Health and Health Equity Research Center Pipeline Products & Ongoing Clinical Trials Overview………………………………………… 236
5.115 University Medical Center Groningen Company Overview………………… 237
5.115.1 University Medical Center Groningen Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 237
5.116 University of Alabama Company Overview……………………………………… 240
5.116.1 University of Alabama Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 240
5.117 University of Birmingham Company Overview…………………………………. 241
5.117.1 University of Birmingham Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 241
5.118 University of Colorado Company Overview……………………………………… 242
5.118.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 242
5.119 University of Kansas Company Overview………………………………………… 244
5.119.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 244
5.120 University of Massachusetts Worcester Campus Company Overview…. 245
5.120.1 University of Massachusetts Worcester Campus Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………. 245
5.121 University of Michigan Pediatric Device Consortium Company Overview……………………………………………………………………………………………………………. 246
5.121.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………… 246
5.122 University of Nebraska Company Overview…………………………………….. 247
5.122.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 247
5.123 University of Nebraska Medical Center Company Overview………………. 248
5.123.1 University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 248
5.124 University of Nevada Reno Company Overview……………………………….. 249
5.124.1 University of Nevada Reno Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 249
5.125 University of North Carolina at Chapel Hill Company Overview…………. 250
5.125.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………. 250
5.126 University of Oxford Company Overview………………………………………… 251
5.126.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 251
5.127 University of South Florida Company Overview……………………………….. 252
5.127.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 252
5.128 University of Texas Health Science Center at San Antonio Company Overview……………………………………………………………………………………………… 253
5.128.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview………………………………………… 253
5.129 University of Texas Medical Branch at Galveston Company Overview… 254
5.129.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………. 254
5.130 University of Texas Southwestern Medical Center Company Overview. 255
5.130.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………… 255
5.131 University of Toledo Company Overview………………………………………… 256
5.131.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 256
5.132 University of Utah Company Overview……………………………………………. 258
5.132.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 258
5.133 University of Washington Company Overview…………………………………. 259
5.133.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 259
5.134 Vertech Inc Company Overview……………………………………………………… 260
5.134.1 Vertech Inc Pipeline Products & Ongoing Clinical Trials Overview.. 260
5.135 Wake Forest School of Medicine Company Overview……………………….. 261
5.135.1 Wake Forest School of Medicine Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 261
5.136 West Virginia University Company Overview…………………………………… 262
5.136.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………………………….. 262
5.137 Wright Medical Group NV (Inactive) Company Overview………………….. 264
5.137.1 Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview………………………………………………………………………. 264
5.138 Yale University Company Overview………………………………………………… 266
5.138.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview……………………………………………………………………………………………………….. 266
5.139 Zimmer Biomet Holdings Inc Company Overview…………………………….. 267
5.139.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview…………………………………………………………………………………. 267
6 Trauma Fixation- Recent Developments……………………………………………………. 270
6.1 Jun 27, 2024: Update for Bioretec’s RemeOs Trauma Screw European Marketing Authorization………………………………………………………………………… 270
6.2 Jun 26, 2024: Medtronic Announces Departure of Karen Parkhill, Chief Financial Officer……………………………………………………………………………………. 270
6.3 Jun 26, 2024: Medtronic CFO Transition and Interim Appointment Update……………………………………………………………………………………………………………. 270
6.4 Jun 25, 2024: Arthrex Receives 510(K) Clearance For Cannulated Screw System…………………………………………………………………………………………………. 270
6.5 Jun 24, 2024: Globus Medical Receives 510(K) Clearance For TENSOR Suture Button System………………………………………………………………………………………. 270
6.6 Jun 19, 2024: aap Implantate Receives 510(K) Clearance For Cannulated Headless Bone Screw…………………………………………………………………………….. 270
6.7 Jun 19, 2024: Eminent Spine Receives 510(K) Clearance For SI Screw System……………………………………………………………………………………………………………. 270
6.8 Jun 19, 2024: Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs trauma screw: fracture healing confirmed in 100% of surgical procedures……………………………………………………………………………. 271
6.9 Jun 19, 2024: OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction……………………………………………………………………. 271
6.10 Jun 18, 2024: Arthrex Receives Additional 510(K) Clearance For Arthrex TightRope II………………………………………………………………………………………….. 272
6.11 Jun 18, 2024: Tyber Medical Receives Additional 510(K) Clearance For Anatomical Plating System……………………………………………………………………… 272
6.12 Jun 18, 2024: Metric Medical Devices Receives 510(K) Clearance For LINK External Fixator…………………………………………………………………………………….. 272
6.13 Jun 18, 2024: Aviva McPherron Joins Orthofix as President of Global Operations and Quality………………………………………………………………………….. 273
6.14 Jun 17, 2024: Medtronic EVP, Global Regions President Rob ten Hoedt is Retiring………………………………………………………………………………………………… 273
6.15 Jun 13, 2024: New Standard Device Receives Additional 510(K) Clearance ForRevolution External Plating System…………………………………………………….. 273
6.16 Jun 13, 2024: Medtronic Confirms Global Layoffs………………………………. 274
6.17 Jun 12, 2024: Microport Endophix’s Megaloop Button System Receives FDA Approval………………………………………………………………………………………………. 274
6.18 Jun 11, 2024: Orthofix Names Julie Dewey Chief Investor Relations and Communications Officer; Max Reinhardt Begins as President of Global Spine. 274
6.19 Jun 10, 2024: Biomet Receives 510(K) Clearance For Kirschner Wire……. 274
6.20 Jun 06, 2024: In2Bones USA Receives Additional 510(K) Clearance For NeoSpan Compression Staple Implant With Instruments…………………………… 275
6.21 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team…………………………………………………………………………….. 275
6.22 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024…………………………………………………………………………………………………….. 275
6.23 May 29, 2024: First European Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System……………………………………………………… 275
6.24 May 23, 2024: Orthofix Names Max Reinhardt President of Global Spine Business……………………………………………………………………………………………….. 276
6.25 May 20, 2024: Synthes Receives FDA 510(k) Clearance for MatrixSTERNUM Fixation System…………………………………………………………………………………….. 276
6.26 May 16, 2024: Suzhou Endophix Receives FDA 510(k) Clearance for Megaloop Button System……………………………………………………………………….. 277
6.27 May 16, 2024: Bioretec Announces Business Review for the Period January–March 2024……………………………………………………………………………… 277
6.28 May 15, 2024: Orthofix Receives FDA 510(k) Clearance for RODEO Telescopic Nail………………………………………………………………………………………. 278
6.29 May 15, 2024: Medacta International Receives FDA 510(k) Clearance for Mbrace Cable……………………………………………………………………………………….. 278
6.30 May 09, 2024: Orthofix Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail………………………………………………………………………………………. 278
6.31 May 09, 2024: Orthoxel Receives FDA 510(K) Clearance for Their Vertex Hip Fracture Nail (HFN)………………………………………………………………………………… 279
6.32 May 08, 2024: Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance……………………………………………………. 280
6.33 May 07, 2024: Ortho Life Systems Receives 510(K) Clearance For XLO Locking Distal Humerus Plating System……………………………………………………. 280
6.34 May 07, 2024: Voom Medical Devices’ Bunionplasty 360 Bunion Repair Solution Offers Modern Alternative to Traditional 3D Approaches……………… 281
6.35 May 07, 2024: Globus Medical Reports First Quarter 2024 Results………. 281
6.36 May 06, 2024: Acumed Receives 510(K) Clearance For Wrist Plating System……………………………………………………………………………………………………………. 282
6.37 May 02, 2024: Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference………………………………………………………………….. 282
6.38 May 02, 2024: Zimmer Biomet Announces First Quarter 2024 Financial Results…………………………………………………………………………………………………. 282
6.39 May 01, 2024: Spinal Simplicity announces FDA 510(k) Clearance of its Sacroiliac Joint System, the Patriot-SI Posterior Implant, With a Unique Hybrid Indication for Use………………………………………………………………………………….. 284
6.40 Apr 30, 2024: TriMed Receives Additional 510(K) Clearance For TriMed ASET Foot Plating System……………………………………………………………………….. 284
6.41 Apr 28, 2024: TriMed Receives 510(K) Clearance For TriMed ASET Foot Plating System (1st Met Osteotomy Plate)……………………………………………….. 285
6.42 Apr 28, 2024: TriMed Receives 510(K) Clearance For TriMed ASET Foot Plating System (H-Plate)…………………………………………………………………………. 285
6.43 Apr 28, 2024: TriMed Receives 510(K) Clearance For TriMed ASET Foot Plating System (Talonavicular Plate)………………………………………………………… 285
6.44 Apr 28, 2024: TriMed Receives 510(K) Clearance For TriMed ASET Foot Plating System (Calcaneal Slide Osteotomy Plate)…………………………………….. 285
6.45 Apr 28, 2024: Medartis Receives Additional 510(K) Clearance For APTUS Foot System………………………………………………………………………………………….. 285
6.46 Apr 25, 2024: CONMED Promotes Patrick Beyer to Chief Operating Officer……………………………………………………………………………………………………………. 286
6.47 Apr 24, 2024: Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour…………………………… 286
6.48 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer………………………………………………………………………………………………….. 287
6.49 Apr 23, 2024: Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024……………………………………………………………… 287
6.50 Apr 23, 2024: Centinel Spine Hits Another Revenue Record in First Quarter 2024 as Prodisc Total Disc Replacement Worldwide Growth Momentum Continues…………………………………………………………………………………………….. 287
6.51 Apr 19, 2024: TDM Receives 510(K) Clearance For Large Bone Plate And Screw System……………………………………………………………………………………….. 288
6.52 Apr 18, 2024: OrthoXel DAC Receives FDA 510(k) Clearance for Vertex Hip Fracture Nailing System…………………………………………………………………………. 288
6.53 Apr 17, 2024: Spinal Elements Launches New Website In Redefining The Aging Spine Solution……………………………………………………………………………… 288
6.54 Apr 17, 2024: SpineGuard Announces Its Full-Year 2023 Financial Results and Its First Quarter 2024 Sales………………………………………………………………. 288
6.55 Apr 16, 2024: Orthofix Names Andres Cedron as New Chief Legal Officer……………………………………………………………………………………………………………. 291
6.56 Apr 13, 2024: Stryker Receives Additional FDA 510(k) Clearance for VariAx 2 Distal Radius System…………………………………………………………………………… 292
6.57 Apr 11, 2024: Bactiguard Holding Announces Annual and Sustainability Report 2023………………………………………………………………………………………….. 292
6.58 Apr 09, 2024: Renowned NYC Foot Surgeon Dr. Stuart J. Mogul Introduces the Revolutionary Lapiplasty Mini-Incision Procedure for Accelerated Healing and Recovery………………………………………………………………………………………… 292
6.59 Apr 04, 2024: Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024…………………………………………………………………. 293
6.60 Apr 02, 2024: Medshape Receives 510(K) Clearance For DynaNail Mini Tapered Hybrid……………………………………………………………………………………… 294
6.61 Apr 02, 2024: DePuy Synthes Receives 510(K) Clearance For VOLT Small Fragment Plating System……………………………………………………………………….. 294
6.62 Apr 02, 2024: Medartis Receives FDA 510(k) Clearance for APTUS Hand Scaphoid Plate………………………………………………………………………………………. 295
6.63 Apr 01, 2024: 4WEB Medical Receives FDA 510(k) Clearance for Ankle Truss System (ATS)…………………………………………………………………………………………. 295
6.64 Apr 01, 2024: Orthofix Receives FDA 510(k) Clearance for FITBONE Transport And Lengthening System…………………………………………………………. 295
6.65 Apr 01, 2024: DePuy Synthes Receives FDA 510(k) Clearance for VOLT Mini Fragment Plating System……………………………………………………………………….. 295
6.66 Mar 29, 2024: Paragon 28 launches new solution for ankle ligament repair……………………………………………………………………………………………………………. 295
6.67 Mar 25, 2024: Jeil Medical Receives FDA 510(k) Clearance for ARIX Cannulated Screw System………………………………………………………………………. 296
6.68 Mar 25, 2024: Treace Celebrates 100,000 Lapiplasty 3D Bunion Correction Patient Milestone………………………………………………………………………………….. 296
6.69 Mar 23, 2024: DePuy Synthes Receives Additional 510(K) Clearance For Milagro Interference Screws…………………………………………………………………… 297
6.70 Mar 22, 2024: Patent allowed for Bioretec’s RemeOs alloy in US…………. 297
6.71 Mar 20, 2024: Outcomes of a Posterior Approach to SI Joint Fusion with LinQ Reflect Clinical Efficacy and Durability at 12 Months………………………….. 298
6.72 Mar 18, 2024: Ossio Receives Additional FDA 510(k) Clearance for OSSIOfiber Trimmable Fixation Nail System……………………………………………… 298
6.73 Mar 18, 2024: Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer…………………………………………………………………………………. 299
6.74 Mar 13, 2024: Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023…………….. 299
6.75 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference…………………………………………………………………………………………… 301
6.76 Mar 11, 2024: Camber Spine Technologies Receives Additional 510(K) Clearance For Sacroiliac (SI) Fixation System…………………………………………….. 301
6.77 Mar 08, 2024: Bioretec’s European Market Authorization for Remeos Trauma Screw Has Proceeded to Expert Panel Evaluation, the Approval Is Estimated During the Q2 2024………………………………………………………………… 301
6.78 Mar 04, 2024: Ortho Solutions Receives 510(K) Clearance For COGNiTiON Staple System……………………………………………………………………………………….. 301
6.79 Mar 01, 2024: Treace Medical Concepts Receives Additional FDA 510(K) Clearance for Treace Medical Concepts (TMC) Plating System……………………. 301
6.80 Mar 01, 2024: Narang Medical Receives 510(K) Clearance For NET Osteosynthesis Nailing System……………………………………………………………….. 302
6.81 Feb 28, 2024: Integra LifeSciences Announces Leadership Transition Plan……………………………………………………………………………………………………………. 302
6.82 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors……. 302
6.83 Feb 24, 2024: Nvision Biomedical Technologies Receives 510(K) Clearance For SnapHammer Hammertoe Correction System…………………………………….. 303
6.84 Feb 22, 2024: ITS Receives 510(K) Clearance For I.T.S. INS Proximal Femur Nail……………………………………………………………………………………………………… 303
6.85 Feb 21, 2024: Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024…………………………… 303
6.86 Feb 20, 2024: Dror Paley, MD to Lead World’s First Surgery with the PRECICE Max System at Paley Orthopedic & Spine Institute……………………….. 304
6.87 Feb 19, 2024: Flow-FX Additional Receives 510(K) Clearance for Flow-Nail……………………………………………………………………………………………………………. 304
6.88 Feb 12, 2024: Enovis to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting………………………. 305
6.89 Feb 12, 2024: Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System………………………………………………………………………………………. 305
6.90 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting…… 306
6.91 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information…………………………………………………………………… 306
6.92 Feb 07, 2024: Tyber Medical’s anatomical plating system receives Health Canada approval……………………………………………………………………………………. 306
6.93 Feb 07, 2024: Bactiguard Holding Appoints Christine Lind as New CEO… 307
6.94 Feb 05, 2024: Nvision Biomedical Technologies Receives Additional FDA 510(k) Clearance for Trigon HA Stand-Alone Wedge Fixation System………….. 308
6.95 Feb 03, 2024: Deltacor Receives 510(K) Clearance For Torpedo Implant System…………………………………………………………………………………………………. 308
6.96 Feb 02, 2024: Intelivation Technologies Announces Commercial Launch of Hammerdesis……………………………………………………………………………………….. 308
6.97 Feb 02, 2024: Treace Announces Interim 3-Year ALIGN3D Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty Procedure…………………………………………………….. 309
6.98 Feb 01, 2024: Treace to Highlight Latest Product Innovations and ALIGN3D Study Outcomes at the 2024 ACFAS Annual Scientific Conference………………. 310
6.99 Feb 01, 2024: Paragon 28 Launches PRECISION MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions…………………………………………………………………………………………. 311
6.100 Feb 01, 2024: Bactiguard Holding Announces Invitation to Presentation of Year-end Report for 2023………………………………………………………………………. 312
6.101 Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth………………………………………………………………….. 312
6.102 Jan 31, 2024: Japan Medical Dynamic Marketing Announces Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March
2024. 312
6.103 Jan 30, 2024: Medline to Launch Lisfranc System at ACFAS 2024 Annual Scientific Conference…………………………………………………………………………….. 313
6.104 Jan 29, 2024: TriMed Received Additional 510(K) Clearance For Threaded Intramedullary Nail System…………………………………………………………………….. 314
6.105 Jan 29, 2024: TDM Receives Additional 510(K) Clearance For TDM Screw System…………………………………………………………………………………………………. 314
6.106 Jan 29, 2024: Tyber Medical Receives FDA Clearance on Plating System Line Extension………………………………………………………………………………………. 314
6.107 Jan 26, 2024: Gm Dos Reis Industria E Comerico Receives FDA 510(k) Clearance for Quick – Radius Disposable Set…………………………………………….. 314
6.108 Jan 18, 2024: Paragon 28 launches Bun-Yo-Matic Lapidus Clamp System……………………………………………………………………………………………………………. 314
6.109 Jan 18, 2024: PainTEQ Announces Successful Completion of First In-Office LinQ Procedure Under New CMS Billing Code…………………………………………… 315
6.110 Jan 17, 2024: New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients………………………. 316
6.111 Jan 11, 2024: Extremity Medical to Expand Orthopedic Extremity Implant Systems Through Strategic Relationship With Henry Schein as Well as Growth Financings…………………………………………………………………………………………….. 316
6.112 Jan 09, 2024: Orthofix Medical Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results…………………………………………………… 317
6.113 Jan 08, 2024: Osteonic Receives Additional 510(K) Clearance For Suture Wing……………………………………………………………………………………………………. 318
6.114 Jan 08, 2024: CoNextions Medical Receives Innovative Technology Contract from Vizient for the CoNextions TR Tendon Repair System…………… 318
6.115 Jan 06, 2024: Sacrix Provides Safe Alternative to Risky Revision Spine Surgery, Publishing Groundbreaking Results in Renowned Spine Journal…….. 319
6.116 Jan 04, 2024: CC-Instruments Receives 510(K) Clearance For CC-Clip Implant System……………………………………………………………………………………… 319
6.117 Jan 04, 2024: Tyber Medical Receives 510(K) Clearance For TM Plating System…………………………………………………………………………………………………. 319
6.118 Jan 04, 2024: Sky Surgical Receives FDA 510(k) Clearance for SkyOPS Orthopedic Plate System………………………………………………………………………… 320
6.119 Jan 04, 2024: Stryker Obtains Additional 510(K) Clearance For Hoffmann LRF (Limb Reconstruction Frame) System………………………………………………… 320
6.120 Jan 04, 2024: Smith & Nephew Receives Additional 510(k) Clearance for Cannulated Screw…………………………………………………………………………………. 320
6.121 Jan 04, 2024: Tyber Medical Receives FDA 510(k) Clearance for Anatomical Plating System – Mini-Frag System Line Extension……………………. 320
6.122 Dec 31, 2023: Tyber Medical Receives Additional 510(K) Clearance For Tyber Medical Anatomical Plating System………………………………………………… 321
6.123 Dec 29, 2023: NuVasive Specialized Orthopedics Receives 510(k) clearance for Precice Max System…………………………………………………………… 321
6.124 Dec 29, 2023: Changzhou Geasure Medical Apparatus and Instruments Receives 510(k) clearance for Internal Locking Plate And Screw Fixation System……………………………………………………………………………………………………………. 321
6.125 Dec 26, 2023: Skeletal Dynamics Receives 510(k) Clearance for Double Internal Joint Stabilizer- Elbow……………………………………………………………….. 321
6.126 Dec 24, 2023: Novastep Receives 510(k) Clearance for arcad
2.0 Duo & Quadro Osteosynthesis Compressive Staple…………………………………………….. 321
6.127 Dec 24, 2023: Spinal Simplicity Receives 510(k) Clearance for Liberty SI Lateral Implant System………………………………………………………………………….. 322
6.128 Dec 21, 2023: Tyber Medical Receives 510(K) Clearance For Distal Radius Plating System………………………………………………………………………………………. 322
6.129 Dec 21, 2023: Voom Medical Devices Redefines Patient Engagement with Launch of Cutting-Edge Website and Doctor Locator for Bunionplasty Procedure……………………………………………………………………………………………………………. 322
6.130 Dec 18, 2023: Riverpoint Medical Receives 510(K) Clearance For IDEAL Ziploop…………………………………………………………………………………………………. 323
6.131 Dec 18, 2023: Tyber Medical Granted FDA Clearance on Distal Radius Plating System………………………………………………………………………………………. 323
6.132 Dec 16, 2023: OSSIO Obtains Additional 510(k) Clearance For OSSIOfiber Trimmable Fixation Nail…………………………………………………………………………. 323
6.133 Dec 14, 2023: Auxein Medical Receives FDA 510(k) Clearance for DHS/DCS Plate System…………………………………………………………………………………………. 324
6.134 Dec 12, 2023: Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company………………………………….. 324
6.135 Dec 11, 2023: Ossio Receives Additional 510(K) Clearance For OSSIOfiber Compression Screw……………………………………………………………………………….. 325
6.136 Dec 06, 2023: OSSIO’s Groundbreaking Option for Fixing Bone Fractures In Children Receives FDA Clearance…………………………………………………………….. 325
6.137 Nov 29, 2023: Ossio Receives Additional 510(K) Clearance For OSSIOfiber Staple…………………………………………………………………………………………………… 327
6.138 Nov 28, 2023: New Shotel Medical Ankle Arthrodesis Device Significantly Improves Patient Quality of Life……………………………………………………………… 327
6.139 Nov 15, 2023: Medartis Receives 510(K) Clearance For APTUS K-Wire System Line Extension……………………………………………………………………………. 327
6.140 Nov 15, 2023: Medartis Receives 510(K) Clearance For APTUS Cannulated Compression Screw Line Extension………………………………………………………….. 328
6.141 Nov 13, 2023: IlluminOss Medical Breaks New Ground in Humerus Fracture Repair……………………………………………………………………………………… 328
6.142 Nov 10, 2023: Astura Medical Receives 510(K) Clearance For REUNION Sacroiliac Joint Fusion System…………………………………………………………………. 328
6.143 Nov 08, 2023: Orthofix Reports Third Quarter 2023 Results………………. 328
6.144 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook………………………………………………………………………………………… 330
6.145 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook……………………………………………………………….. 330
6.146 Nov 02, 2023: Foundation Fusion Solution Receives Additional 510(k) Clearance for TransLoc 3D……………………………………………………………………… 331
6.147 Nov 02, 2023: Medline Industries Receives Additional 510(k) Clearance for UNITE REFLEX Nitinol Staple System………………………………………………………… 332
6.148 Nov 01, 2023: FDA grants clearance to Xenix Medical’s SOLACE system 332
6.149 Oct 31, 2023: CONMED Corp. to Participate in Fireside Chats at Two Investor Conferences on November 14-15……………………………………………….. 332
6.150 Oct 30, 2023: Japan Medical Dynamic Marketing Announces Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 2024……………………………………………………………………………………………………………. 333
6.151 Oct 27, 2023: Bactiguard Holding Announces Interim Report Q3
2023.. 334
6.152 Oct 25, 2023: HSS Appoints New Leadership in Neurology and Anesthesia……………………………………………………………………………………………………………. 336
6.153 Oct 19, 2023: Exactech Receives Additional 510(k) Clearance for Equinoxe Proximal Humerus Fracture Plate……………………………………………………………. 337
6.154 Oct 19, 2023: OrthoPediatrics Launches Pediatric Nailing Platform | Tibia……………………………………………………………………………………………………………. 337
6.155 Oct 18, 2023: Bioretec Estimates that the Approval of the European market Authorization for the biodegradable RemeOs Trauma Screw Will Move to the First Quarter of 2024……………………………………………………………………. 337
6.156 Oct 17, 2023: Groundbreaking Advancement in Minimally Invasive Bunion Surgery (MIBS): Voom Medical Devices Introduces Next Generation, Functionally Distinctive Patented Screw…………………………………………………… 338
6.157 Oct 16, 2023: LESspine Receives 510(K) Clearance For FacetFuse Screw Fixation System…………………………………………………………………………………….. 338
6.158 Oct 16, 2023: FDA clears DePuy Synthes’s foot and ankle plating system……………………………………………………………………………………………………………. 338
6.159 Oct 13, 2023: Spinal Elements to Feature the Karma, An Aging Spine, Metal-Free Fixation Solution, at Upcoming 38th Annual Meeting of the North American Spine Society………………………………………………………………………….. 339
6.160 Oct 11, 2023: SpineGuard Announces its Q3 2023 Revenue………………. 340
6.161 Oct 10, 2023: New Paradigm Biomedical Receives 510(k) Clearance for Para-Fix External Fixation System……………………………………………………………. 341
6.162 Oct 09, 2023: Stryker to Host Investor Day………………………………………. 341
6.163 Oct 05, 2023: Curvafix Showcases Novel, Curved Intramedullary Devices for Pelvic Fixation at ACEP Scientific Assembly…………………………………………. 341
6.164 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business…………………………………………………………………….. 342
6.165 Oct 02, 2023: Ossio Receives Additional 510(k) clearance for OSSIOfiber Cannulated Trimmable Fixation Nail………………………………………………………… 342
6.166 Oct 02, 2023: Trax Surgical Obtains 510(k) Clearance for Accelerate Compression Screw System……………………………………………………………………. 342
6.167 Oct 02, 2023: Intelivation Obtains Additional 510(k) Clearance for Hammerdesis Interphalangeal Fusion System…………………………………………… 342
6.168 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023…………………………………………………………………………………. 343
6.169 Sep 28, 2023: Merz Aesthetics Continues to Fuel Confidence by Expanding Belotero Balance (+) Filler Treatment Areas……………………………………………… 343
6.170 Sep 27, 2023: Vilex Receives 510(k) Clearance for TITANEX ARTEMIS Screw System…………………………………………………………………………………………………. 344
6.171 Sep 27, 2023: Vilex Receives 510(k) Clearance for TITANEX MICROBEAM Screw System……………………………………………………………………………………….. 344
6.172 Sep 27, 2023: Acuitive Technologies Receives FDA 510(k) Clearance for CITRELOCK DUO a New Sports Medicine Fixation Device for Biceps Tenodesis and Tendon Transfer Procedures…………………………………………………………….. 344
6.173 Sep 26, 2023: Innovate Orthopaedics Receives 510(k) Clearance for Quick-Start Orthopaedic Fixation Screw And Reverse Thread Screw…………………….. 345
6.174 Sep 25, 2023: OrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting……………………………………………………. 345
6.175 Sep 21, 2023: Tyber Medical Gains FDA and MDR Clearance for Its Implantable K-Wires and Steinmann Pins in Stainless Steel and Titanium Alloy……………………………………………………………………………………………………………. 345
6.176 Sep 20, 2023: Stryker introduces new internal fixation system to treat bunions………………………………………………………………………………………………… 346
6.177 Sep 20, 2023: Treace Highlights New Product Innovations and Updated ALIGN3D Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023…………………………………………………………………………….. 347
6.178 Sep 18, 2023: MiRus Announces Launch of Molybdenum-Rhenium Low Profile ATLAS MoRe Foot and Ankle Plating System………………………………….. 348
6.179 Sep 14, 2023: A Plus Biotechnology Receives 510(k) Clearance for APS Metal Plate & Screw System…………………………………………………………………… 348
6.180 Sep 14, 2023: Paragon 28 Receives Additional 510(k) Clearance for Titan 3-D Wedge System………………………………………………………………………………… 348
6.181 Sep 14, 2023: Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent 349
6.182 Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board……………………………………………………………………………………… 349
6.183 Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business……………………………………………………………………………………………….. 349
6.184 Sep 14, 2023: Smith & Nephew Announces Board Changes………………. 349
6.185 Sep 12, 2023: Inside information: Bioretec Enters into the U.S. Distribution Agreement with Spartan Medical for the RemeOs Screws……….. 350
6.186 Sep 12, 2023: Stryker’s Pangea Systems Receive FDA Clearance………… 351
6.187 Sep 12, 2023: Orthofix Announces Leadership Changes……………………. 352
6.188 Sep 12, 2023: SpineGuard Reports Six-Month 2023 Financial Results…. 353
6.189 Sep 11, 2023: OrthoPediatrics Receives FDA 510(K) Clearance for Pediatric Nailing Platform | Tibia………………………………………………………………………….. 354
6.190 Sep 11, 2023: Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures…………………………………………………………………………………………… 355
6.191 Sep 08, 2023: OrthoPediatrics Receives 510(k) Clearance for Pediatric Nailing Platform – Tibia…………………………………………………………………………… 355
6.192 Sep 07, 2023: NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets………………………………………………………….. 355
6.193 Sep 06, 2023: PainTEQ Launches World’s First Surgery-Ready Instruments for Posterior Approach with LinQ……………………………………………………………. 356
6.194 Sep 06, 2023: Bioretec Has Received Business Finland’s R&D Grant for Developing Coatings for the Next Generation of Biodegradable Implants……. 356
6.195 Sep 06, 2023: Forma Medical Launches OptimalHT the World’s First Minimally Invasive Instrumented Hammertoe Arthrodesis Procedure After 50+ Procedures…………………………………………………………………………………………… 357
6.196 Sep 05, 2023: Microware Precision Receives Additional 510(k) Clearance for Tandry Locking Plate System……………………………………………………………… 358
6.197 Sep 05, 2023: Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team…………………………………………………………………….. 358
6.198 Aug 30, 2023: NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting………………………………………………. 359
6.199 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair…………………………………………………………………………………………. 359
6.200 Aug 25, 2023: Electro-Spec Receives 510(k) Clearance for Steri-Caps…. 359
6.201 Aug 25, 2023: Xenix Medical Receives 510(k) Clearance for Sacroiliac Fixation System…………………………………………………………………………………….. 359
6.202 Aug 24, 2023: Stryker Receives 510(k) Clearance for Pangea Fibula Plating System…………………………………………………………………………………………………. 359
6.203 Aug 24, 2023: Stryker Receives 510(k) Clearance for Pangea Tibia Plating System…………………………………………………………………………………………………. 360
6.204 Aug 24, 2023: Stryker Receives 510(k) Clearance for Pangea Humerus Plating System………………………………………………………………………………………. 360
6.205 Aug 24, 2023: Stryker Receives 510(k) Clearance for Pangea Femur Plating System…………………………………………………………………………………………………. 360
6.206 Aug 24, 2023: Stryker Receives 510(k) Clearance for Pangea Utility Plating System…………………………………………………………………………………………………. 360
6.207 Aug 24, 2023: Medartis Receives 510(k) Clearance for Sterile APTUS System…………………………………………………………………………………………………. 360
6.208 Aug 22, 2023: Zimmer Biomet Holdings Receives Additional 510(k) clearance for Natural Nail System Cephalomedullary Nail………………………….. 360
6.209 Aug 22, 2023: Zimmer Receives Additional 510(k) clearance for AFFIXUS Natural Nail System Humeral Nail……………………………………………………………. 361
6.210 Aug 22, 2023: Medline Industries Receives Additional 510(k) clearance for UNITE REFLEX Nitinol Staple System………………………………………………………… 361
6.211 Aug 22, 2023: Vilex in Tennessee Receives 510(k) Clearance for Nitinex Memory Compression Implant……………………………………………………………….. 361
6.212 Aug 22, 2023: Zimmer Biomet Announces Leadership Transition………. 361
6.213 Aug 21, 2023: Arthrex Receives Additional 510(k) Clearance for Arthrex TightRope II………………………………………………………………………………………….. 362
6.214 Aug 18, 2023: Restor3d Receives 510(k) Clearance for Extremity Staple 362
6.215 Aug 18, 2023: Healthium Medtech Receives 510(k) Clearance for T-Button A Adjustable Loop UHMWPE Suture PEEK Button……………………………………… 363
6.216 Aug 18, 2023: Healthium Medtech Receives 510(k) Clearance for T-Button S Adjustable Loop UHMWPE Suture PEEK Button Open Button………………….. 363
6.217 Aug 18, 2023: Globus Medical Receives 510(k) Clearance for STRETTO Cable System………………………………………………………………………………………… 363
6.218 Aug 16, 2023: SurGenTec Receives an Additional 510(k) Clearance for TiLink-L SI Joint Fusion System………………………………………………………………… 363
6.219 Aug 15, 2023: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance……………… 363
6.220 Aug 14, 2023: DePuy Synthes Receives Additional 510(k) Clearance for MAXFRAME Multi-Axial Correction System………………………………………………. 364
6.221 Aug 10, 2023: S.B.M Science For Bio Materials Receives 510(k) Clearance for ecoFIX…………………………………………………………………………………………….. 364
6.222 Aug 10, 2023: Riverpoint Medical Receives 510(k) Clearance for HS Fiber Cerclage……………………………………………………………………………………………….. 364
6.223 Aug 10, 2023: In2Bones Receives 510(k) Clearance for IBS-B MIS Beveled Screw System……………………………………………………………………………………….. 365
6.224 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024…………………………………………………………………….. 365
6.225 Aug 03, 2023: Karma’s PEEK Posterior Fixation Strap Proved Safe and Reproducible in Recently Published Clinical Article……………………………………. 365
6.226 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook…………………………………………………………………………………. 366
6.227 Jul 31, 2023: Arthrex Receives 510(k) Clearance for Intramedullary Fixation Nail………………………………………………………………………………………….. 369
6.228 Jul 31, 2023: Forma Medical Receives 510(k) Clearance for Headless Compression Screw……………………………………………………………………………….. 369
6.229 Jul 31, 2023: Jeil Medical Receives an Additional 510(k) Clearance for ARIX Ankle System………………………………………………………………………………………… 369
6.230 Jul 31, 2023: Bonebridge Receives Additional 510(k) Clearance for TAMlNA
3.5mm Proximal Humerus System……………………………………………… 369
6.231 Jul 31, 2023: Fortis Malar Hospitals Notice of 32Nd Annual General Meeting……………………………………………………………………………………………….. 370
6.232 Jul 28, 2023: Bonebridge Receives 510(K) Clearance for LORRAINE
3.5mm Distal Humerus System………………………………………………………………………….. 370
6.233 Jul 28, 2023: Bonebridge Receives 510(K) Clearance for POYA
3.5MM Lateral Proximal Tibia System…………………………………………………………………. 371
6.234 Jul 28, 2023: Japan Medical Dynamic Marketing Announces Summary of Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 2024………………………………………………………………………………………….. 371
6.235 Jul 20, 2023: Device for Treating Challenging Bone Fractures Cleared by FDA……………………………………………………………………………………………………… 372
6.236 Jul 17, 2023: Tyber Medical Receives 510(k) Clearance for Pin and Wire System…………………………………………………………………………………………………. 373
6.237 Jul 14, 2023: OsteoCentric Technologies Receives 510(k) Clearance for ACL Fixation System…………………………………………………………………………………….. 373
6.238 Jul 14, 2023: Bioretec appoints Esa Hallinen as a director of operations and a member of the Management Team………………………………………………… 373
6.239 Jul 13, 2023: Changzhou Geasure Medical Apparatus and Instruments Receives 510(k) Clearance for SGM Femoral Nail System…………………………… 373
6.240 Jul 12, 2023: SI-Bone Receives Additional 510(k) Clearance for iFuse-TORQ Implant System……………………………………………………………………………………… 374
6.241 Jul 12, 2023: University of Utah Health Care Receives 510(k) Clearance for Bone Bolt System………………………………………………………………………………….. 374
7 Appendix……………………………………………………………………………………………….. 375
7.1 Methodology…………………………………………………………………………………… 375
7.2 About GlobalData…………………………………………………………………………….. 378
7.3 Contact Us………………………………………………………………………………………. 378
7.4 Disclaimer……………………………………………………………………………………….. 378
